Navigation Links
Talecris Biotherapeutics Enrolls Patients in Clinical Trial Evaluating Two Doses of PROLASTIN®-C
Date:12/9/2010

e expressed or implied in forward-looking statements: possible U.S. legislation or regulatory action affecting, among other things, the U.S. healthcare system, pharmaceutical pricing and reimbursement, including Medicaid and Medicare; our ability to procure adequate quantities of plasma and other materials which are acceptable for use in our manufacturing processes from our own plasma collection centers or from third-party vendors; our ability to maintain compliance with government regulations and licenses, including those related to plasma collection, production and marketing; our ability to identify growth opportunities for existing products and our ability to identify and develop new product candidates through our research and development activities; and the timing of, and our ability to, obtain and/or maintain regulatory approvals for new product candidates, the rate and degree of market acceptance, and the clinical utility of our products.  Additional information about factors that could affect the business and financial results of Talecris is contained in its final Prospectus filed pursuant to Rule 424(b)(1) with the Securities and Exchange Commission on October 1, 2009. Talecris undertakes no duty to update any forward-looking statement.


'/>"/>
SOURCE Talecris Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Talecris Biotherapeutics Launches PROLASTIN®-C in Canada
2. Talecris Biotherapeutics Receives FDA Approval for Gamunex®-C
3. Talecris Biotherapeutics to Report Third Quarter 2010 Financial Results
4. Talecris Biotherapeutics CEO Accepts 2010 Ernst & Young Entrepreneur Of The Year Award on Behalf of Employees and Patients
5. Talecris Forms Partnership to Co-Promote Life-Saving Rabies Products
6. Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
7. Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial
8. Protalix BioTherapeutics to Present at Two Upcoming Healthcare Conferences
9. Garnet BioTherapeutics Announces First Patient Treated in Trial of New Therapy for Improvement in Scar Appearance
10. NASDAQ Trading for Oxygen Biotherapeutics, Inc. Shares to Begin January 15, 2010
11. Oxygen Biotherapeutics, Inc. Announces Approval for NASDAQ Listing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... -- Insulet Corporation (NASDAQ: PODD ), the leader in ... Insulin Management System, today announced that Dr. Jessica ... Directors. Dr. Hopfield brings more than two ... She currently serves as the Vice Chair of the ... diabetes research center, diabetes clinic, and provider of diabetes ...
(Date:7/28/2015)... July 28, 2015  Edwards Lifesciences Corporation (NYSE: EW ... valves and hemodynamic monitoring, today reported net income for ... $1.02 per diluted share.  Adjusted net income on a ... share, compared to $0.88 per diluted share in the ... net income was $5.09 per diluted share, which included ...
(Date:7/28/2015)...   Heska Corporation  (NASDAQ:  HSKA -  News ; ... veterinary diagnostic and other specialty veterinary products , ... i ® Immunodiagnostic Analyzer. Element i performs ... concerns, including thyroid disorders, Cushing,s disease and Addison,s ... top analyzer that delivers rapid immunoassay testing, including ...
Breaking Medicine Technology:Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3Edwards Lifesciences Reports Second Quarter Results 2Edwards Lifesciences Reports Second Quarter Results 3Edwards Lifesciences Reports Second Quarter Results 4Edwards Lifesciences Reports Second Quarter Results 5Edwards Lifesciences Reports Second Quarter Results 6Edwards Lifesciences Reports Second Quarter Results 7Edwards Lifesciences Reports Second Quarter Results 8Edwards Lifesciences Reports Second Quarter Results 9Edwards Lifesciences Reports Second Quarter Results 10Edwards Lifesciences Reports Second Quarter Results 11Edwards Lifesciences Reports Second Quarter Results 12Edwards Lifesciences Reports Second Quarter Results 13Edwards Lifesciences Reports Second Quarter Results 14Edwards Lifesciences Reports Second Quarter Results 15Edwards Lifesciences Reports Second Quarter Results 16Edwards Lifesciences Reports Second Quarter Results 17Edwards Lifesciences Reports Second Quarter Results 18Edwards Lifesciences Reports Second Quarter Results 19Edwards Lifesciences Reports Second Quarter Results 20Edwards Lifesciences Reports Second Quarter Results 21Edwards Lifesciences Reports Second Quarter Results 22Edwards Lifesciences Reports Second Quarter Results 23Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 2Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 3
... Adeona Pharmaceuticals, Inc. (AMEX: AEN ), a ... reported its second quarter 2011 financial results for the period ended ... the second quarter. Updates since the beginning of ... Multiple Sclerosis (MS) ...
... Aug. 15, 2011 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTCBB: ... and seller of medicine and drugs in the People,s ... for the quarter ended June 30, 2011. Summary financial ... Quarter Financial Highlights Revenues for ...
Cached Medicine Technology:Adeona Reports Second Quarter 2011 Financial Results 2Adeona Reports Second Quarter 2011 Financial Results 3Adeona Reports Second Quarter 2011 Financial Results 4Adeona Reports Second Quarter 2011 Financial Results 5Adeona Reports Second Quarter 2011 Financial Results 6Adeona Reports Second Quarter 2011 Financial Results 7Adeona Reports Second Quarter 2011 Financial Results 8Adeona Reports Second Quarter 2011 Financial Results 9Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 2Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 3Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 4Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 5Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 6Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 7
(Date:7/28/2015)... Jose, CA (PRWEB) , ... July 28, 2015 ... ... services, intelligent gateways, and embedded building blocks for edge devices that enable the ... equipped with 4th generation Intel® Core™ i7/i5 processor to provide exceptional computing power ...
(Date:7/28/2015)... ... 28, 2015 , ... Dr. Aziz Ahmad recently gave a talk on the ... to 1 p.m. Tuesday, June 23, at the Gulf Coast Regional Medical Center Large ... board-certified in colorectal surgery and has more than 35 years of experience in the ...
(Date:7/28/2015)... ... July 28, 2015 , ... Egg freezing ... procedure to help ensure future fertility. As Dr. Michael Kettel explained in ... is an option that wasn’t available for previous generations who had to make choices ...
(Date:7/28/2015)... , ... July 28, 2015 , ... BMI of Texas, ... offering the duodenal switch weight loss surgery procedure. Committed to helping patients ... surgery procedures, BMI of Texas is one of the first practices in ...
(Date:7/28/2015)... CA (PRWEB) , ... July 28, 2015 , ... Bipolar ... several times a day to a few times a year. The World Health Organization ... study by the National Institute of Mental Health reveals that the United States has ...
Breaking Medicine News(10 mins):Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 3Health News:Dr. Aziz Ahmad Delivers Talk at Gulf Coast Medical Center 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 3Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 2Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 3Health News:"I Am Not I" Music Video Raises Bipolar Disorder Awareness 2
... circumcised can enjoy the same levels of sexual satisfaction and ... of nearly 4,500 males published in the January issue of ... carried out by researchers from Uganda and the USA, was ... is now recommended as an efficient way to reduce HIV ...
... air pollution significantly reduces foetus size during pregnancy, according ... University of Technology senior research fellow Dr Adrian Barnett ... than 15,000 ultrasound scans in Brisbane to air pollution ... "The study found that mothers with a higher exposure ...
... than their white counterparts to receive therapy for various ... in treatment, according to a study by researchers at ... online issue of the journal Cancer. , Prior research ... 1990s. Cary P. Gross, M.D., associate professor of medicine ...
... Findings from large study show a trend, but reasons aren,t ... father children may be at higher risk of prostate cancer ... study suggests. , The large-scale study looked at all men ... childless men had a 17 percent lower incidence of prostate ...
... Insulet,s OmniPod(R) Personal Diabetes Manager to Integrate DexCom ... Continuous Glucose Monitoring Technology, ... Insulet,Corporation (Nasdaq: PODD ), the leader in wearable ... DexCom, Inc. (Nasdaq:,DXCM), a leading provider of continuous glucose ...
... Research announces the,availability of TraderNotes on stocks that ... all of the daily trading notes for free ... Cereplast, Inc. (OTC Bulletin Board:,CERP), Origin Agritech Limited ... OSIR ), Gulf Resources (OTC Bulletin Board: GFRE), ...
Cached Medicine News:Health News:Circumcision doesn't reduce sexual satisfaction and performance, says study of 4,500 men 2Health News:Pollution shrinks fetus size: Brisbane study finds 2Health News:Despite efforts, significant racial disparities in cancer therapy still exist 2Health News:Fatherhood Tied to Higher Prostate Cancer Risk 2Health News:Fatherhood Tied to Higher Prostate Cancer Risk 3Health News:Insulet Corporation and DexCom Announce Development Agreement 2Health News:Insulet Corporation and DexCom Announce Development Agreement 3Health News:Insulet Corporation and DexCom Announce Development Agreement 4Health News:Insulet Corporation and DexCom Announce Development Agreement 5Health News:Insulet Corporation and DexCom Announce Development Agreement 6Health News:Beacon Research Issues TraderNotes on CERP, SEED, OSIR, GFRE, RIMM 2Health News:Beacon Research Issues TraderNotes on CERP, SEED, OSIR, GFRE, RIMM 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: